CapitolRadar tracks every publicly disclosed XYL trade by US congress members and corporate insiders: 27 disclosed trades (19 buys, 8 sells) by 2 tracked traders, from 2019-04-12 to 2026-09-25. Updated daily from official filings.
Want a ping when Congress buys XYL? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Xylem Inc. (XYL) — Industrials · Industrial - Machinery, market cap about $24.0B.
Cluster watch: 3 distinct tracked traders disclosed buying XYL in the last 45 days: Ro Khanna, van der Berg Andrea Michele (officer: EVP & Chief Financial Officer), Johnston Joseph Patrick (officer: EVP & President, AW).
CapitolRadar analysis
27 trades, with buys accounting for 19
XYL has 27 tracked congressional trades from 2019-04-12 through 2026-09-25: 19 buys and 8 sells. The activity came from only 2 distinct traders, so the apparent buy-heavy balance reflects a very small group rather than broad participation. Xylem Inc. is classified in the Industrials sector and the Industrial - Machinery industry.
Ro Khanna accounted for 15 of the 19 buys, with the latest dated 2026-09-25. Susie Lee accounted for the other 4 buys, most recently on 2019-07-12. That concentration is important: the complete tracked buying record is attributable to just two people, and Khanna represents most of it.
6 buys across 2026 Q2 and Q3
Recent activity was concentrated in 2026. Q3 had 3 trades, including 2 buys, while Q2 had 3 trades and all 3 were buys. Q1 recorded 1 trade and no buys. Earlier listed quarters were less consistent: 2025 Q2 and 2024 Q1 each had 1 trade, both buys; 2023 Q4 had 3 trades, all buys; and 2023 Q3 plus Q2 combined for 3 trades with no buys.
These quarterly counts are small, making shifts between all-buy and no-buy periods sensitive to only a few disclosures. The listed quarters also do not cover every quarter within the full 2019-to-2026 tracking span.
6 overlapping tickers, each linked to one buyer
Among the two XYL buyers, 1 also bought each of ALIZY, AVGO, BSX, CMCSA, CTAS and DXCM. The data does not identify which buyer made each overlapping purchase, and one-person overlap is too limited to establish a broader pattern.
Congressional transaction reports can appear with a disclosure lag of up to 45 days, so trade dates and public availability may differ. Reported amount ranges, when used, are estimates rather than exact transaction values; no amount ranges are provided here. These timing and sizing limitations, combined with the two-trader sample, constrain interpretation.
Analysis written from the tracked record on 2026-10-13; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 3 | 2 | 1 |
| 2026 Q2 | 3 | 3 | 0 |
| 2026 Q1 | 1 | 0 | 1 |
| 2025 Q2 | 1 | 1 | 0 |
| 2024 Q1 | 1 | 1 | 0 |
| 2023 Q4 | 3 | 3 | 0 |
| 2023 Q3 | 1 | 0 | 1 |
| 2023 Q2 | 2 | 0 | 2 |
Who is buying XYL?
Disclosed trades in XYL
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-09-11 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-07-07 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-06-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-05-01 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-04-13 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-01-29 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-06-06 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2024-02-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-11-03 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2023-10-10 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-08-03 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-06-29 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-05-23 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2022-11-30 | Susie Lee | sell | $1,001 - $15,000 | — |
| 2022-07-19 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2022-05-23 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2022-05-10 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2022-02-17 | Ro Khanna | sell | $15,001 - $50,000 | — |
CapitolRadar signal history
NEW PICK 2026-09-02
Xylem CFO Andrea Michele van der Berg disclosed a roughly $645,000 stock purchase, alongside another recent insider buyer. The trade fell short mainly because its September 2026 date is in the future and could not be verified, making the signal unreliable. A matching SEC filing confirming the date, price, and open-market purchase would have strengthened the case enough to reconsider the verdict.
These buyers also bought
Other stocks the tracked buyers of XYL disclosed buying in the last six months: AMD (1) · BAX (1) · CASY (1) · COF (1) · CVS (1) · ES (1).
About Xylem Inc.
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco br…
Frequently asked questions
Which politicians bought XYL most?
Ro Khanna leads with 15 disclosed buys, followed by Susie Lee.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.